# reload+after+2024-01-22 05:45:02.482967
address1§16 Tiomkin Street
city§Tel Aviv
zip§6578317
country§Israel
phone§972 3 693 8448
fax§972 3 693 8447
website§https://www.galmedpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Allen  Baharaff', 'age': 58, 'title': 'Co-Founder, President, CEO & Chairman', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 803501, 'exercisedValue': 0, 'unexercisedValue': 146192}, {'maxAge': 1, 'name': 'Mr. Doron  Cohen', 'age': 56, 'title': 'Chief Financial Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 175332, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Guy  Nehemya', 'age': 38, 'title': 'COO & Data Protection Officer', 'yearBorn': 1985, 'fiscalYear': 2022, 'totalPay': 235560, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Yohai  Stenzler CPA', 'age': 40, 'title': 'Chief Accounting Officer', 'yearBorn': 1983, 'fiscalYear': 2022, 'totalPay': 239482, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Liat  Hayardeny', 'age': 56, 'title': 'Chief Scientific Officer', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 125243, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Yael  Hollander', 'age': 40, 'title': 'Vice President of Legal Affairs & Strategy', 'yearBorn': 1983, 'fiscalYear': 2022, 'totalPay': 134214, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Shani  Ganon', 'title': 'Human Resources Manager', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tali  Gorfine', 'age': 53, 'title': 'Medical Consultant', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 202763, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.939
currency§USD
dateShortInterest§1702598400
forwardEps§-1.29
pegRatio§-0.01
exchange§NCM
quoteType§EQUITY
shortName§Galmed Pharmaceuticals Ltd.
longName§Galmed Pharmaceuticals Ltd.
firstTradeDateEpochUtc§1394717400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ade4d27e-0850-308a-ae7b-98b5c772bca9
gmtOffSetMilliseconds§-18000000
targetHighPrice§1.0
targetLowPrice§1.0
targetMeanPrice§1.0
targetMedianPrice§1.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§6.735
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
